Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

The activity of lowering intraocular pressure of cassiae seed extract in a DBA/2J mouse glaucoma model.

Horng CT, Tsai ML, Chien ST, Kao WT, Tsai MK, Chang TH, Chen FA.

J Ocul Pharmacol Ther. 2013 Feb;29(1):48-54. doi: 10.1089/jop.2011.0214.

PMID:
23039184
2.

Effect of Antiglaucoma Medicine on Intraocular Pressure in DBA/2J Mice.

Sawada K, Hiraoka M, Ohguro H.

Ophthalmic Res. 2016;55(4):205-11. doi: 10.1159/000444057.

PMID:
26942413
3.

Effects of Dorzolamide on Retinal and Choroidal Blood Flow in the DBA/2J Mouse Model of Glaucoma.

Chandra S, Muir ER, Deo K, Kiel JW, Duong TQ.

Invest Ophthalmol Vis Sci. 2016 Mar;57(3):826-31. doi: 10.1167/iovs.15-18291.

4.
5.
6.
7.

Investigating the effect of ciliary body photodynamic therapy in a glaucoma mouse model.

Matsubara A, Nakazawa T, Husain D, Iliaki E, Connolly E, Michaud NA, Gragoudas ES, Miller JW.

Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2498-507.

PMID:
16723462
8.

Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients.

Liu CJ, Ko YC, Cheng CY, Chiu AW, Chou JC, Hsu WM, Liu JH.

Ophthalmology. 2002 Dec;109(12):2241-7.

PMID:
12466165
9.

Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension.

Katz LJ, Simmons ST, Craven ER.

Curr Med Res Opin. 2007 Dec;23(12):2971-83. Review.

PMID:
17949534
10.
11.
12.

Pharmacokinetics and intraocular pressure lowering effect of timolol preparations in rabbit eyes.

Chiang CH, Ho JI, Chen JL.

J Ocul Pharmacol Ther. 1996 Winter;12(4):471-80.

PMID:
8951683
13.

Intraocular pressure-lowering activity of topical application of Aegle marmelos fruit extract in experimental animal models.

Agarwal R, Gupta SK, Srivastava S, Saxena R, Agrawal SS.

Ophthalmic Res. 2009;42(2):112-6. doi: 10.1159/000226216.

PMID:
19556826
14.

Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study.

Katz LJ, Rauchman SH, Cottingham AJ Jr, Simmons ST, Williams JM, Schiffman RM, Hollander DA.

Curr Med Res Opin. 2012 May;28(5):781-8. doi: 10.1185/03007995.2012.681036.

PMID:
22458918
15.

Assessment of aqueous humor dynamics in the mouse by a novel method of constant-flow infusion.

Millar JC, Clark AF, Pang IH.

Invest Ophthalmol Vis Sci. 2011 Feb 3;52(2):685-94. doi: 10.1167/iovs.10-6069.

PMID:
20861483
16.
17.

Twice-daily brinzolamide/brimonidine fixed combination versus brinzolamide or brimonidine in open-angle glaucoma or ocular hypertension.

Aung T, Laganovska G, Hernandez Paredes TJ, Branch JD, Tsorbatzoglou A, Goldberg I.

Ophthalmology. 2014 Dec;121(12):2348-55. doi: 10.1016/j.ophtha.2014.06.022. Erratum in: Ophthalmology. 2015 Oct;122(10):2149.

PMID:
25064721
18.

Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.

Rosenberg LF, Krupin T, Tang LQ, Hong PH, Ruderman JM.

Ophthalmology. 1998 Jan;105(1):88-92; discussion 92-3.

PMID:
9442783
19.

Comparison of acetazolamide, brimonidine, and anterior chamber paracentesis for ocular hypertension control after initial intravitreal bevacizumab injection: a randomized clinical trial.

Katayama BY, Bonini-Filho MA, Messias AM, Paula JS, Martin LF, Costa R, Jorge R.

J Glaucoma. 2014 Sep;23(7):461-3. doi: 10.1097/IJG.0b013e3182948476.

PMID:
23632404
20.

Rescue of retinal function by BDNF in a mouse model of glaucoma.

Domenici L, Origlia N, Falsini B, Cerri E, Barloscio D, Fabiani C, Sansò M, Giovannini L.

PLoS One. 2014 Dec 23;9(12):e115579. doi: 10.1371/journal.pone.0115579.

Items per page

Supplemental Content

Support Center